Drug loading and release from electrospun biodegradable nanofibers

Journal of Biomedical Nanotechnology

Volumn 10, Issue 9, 2014, Pages 2173-2199

  Goonoo, Nowsheen ^a   Bhaw Luximon, Archana ^a   Jhurry, Dhanjay ^a  

^a UNIVERSITY OF MAURITIUS   (Mauritius)

Author keywords

Drug eluting fiber mats; Drug incorporating techniques; Electrospinning; Nanofibers

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADABLE POLYMERS; BIODEGRADATION; BLENDING; DRUG DELIVERY; DRUG PRODUCTS; ELECTROSPINNING; MECHANICAL PROPERTIES; NANOFIBERS; SCAFFOLDS; SCAFFOLDS (BIOLOGY);

COAXIAL ELECTROSPINNING; DRUG DELIVERY APPLICATIONS; DRUG INCORPORATING TECHNIQUES; ELECTROSPUN NANOFIBERS; ELECTROSPUN NANOSTRUCTURES; FIBER MAT; MECHANICAL PERFORMANCE; PROCESSING PARAMETERS;

LOADING;

ELECTROSPUN NANOFIBER; GROWTH FACTOR; NANOFIBER; NANOMATERIAL; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; BIOMATERIAL;

ADSORPTION; BIOCOMPATIBILITY; BIODEGRADABILITY; CHEMICAL MODIFICATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; DRUG TARGETING; ELECTROSPINNING; EMULSION; GENE TARGETING; MOLECULAR WEIGHT; NONHUMAN; PHYSICAL CHEMISTRY; POLYMERIZATION; POROSITY; REVIEW; SURFACE PROPERTY; WOUND DRESSING; ANIMAL; CHEMISTRY; HUMAN; NANOTECHNOLOGY; PROCEDURES; ULTRASTRUCTURE;

ANIMALS; BIOCOMPATIBLE MATERIALS; DRUG DELIVERY SYSTEMS; HUMANS; NANOFIBERS; NANOTECHNOLOGY;

EID: 84898770671     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2014.1885     Document Type: Review

References (238)

1. H. S. Nalwa (ed.), Handbook of Nanostructured Materials and Nanotechnology, Academic Press, San Diego, CA (2000), Vol. 5.
2. E. R. Kenawy, F. I. Abdel Hay, M. H. El-Newehy, and G. E. Wnek, Processing of polymer nanofibers through electrospinning as drug delivery systems. Mater. Chem. Phys. 113, 296 (2009).
3. M. Ramalingam, S. Ramakrishna, and G. Rutledge, A special section on advances in electrospinning of nanofibers and their biomedical applications. J. Nanosci. Nanotechnol. 13, 4645 (2013).
4. P. C. Carracciolo, P. R. Cortez-Tornello, F. M. Ballarin, and G. A. Abraham, Development of electrospun nanofibers for biomedical applications: State of the art in Latin America. J. Biomater. Tissue Eng. 3, 39 (2013).
5. W. Cui, Y. Zhou, and J. Chang, Electrospun nanofibrous materials for tissue engineering and drug delivery. Sci. Technol. Adv. Mater. 11, 014108 (2010).
6. M. V. Natu, H. C. de Sousa, and M. H. Gil, Effects of drug solubility, state and loading on controlled release in bicomponent electrospun fibers. Int. J. Pharm. 397, 50 (2010).
7. G. R. Williams, N. P. Chatterton, T. Nazir, D. G. Yu, L. M. Zhu, and C. J. Branford-White, Electrospun nanofibers in drug delivery: Recent developments and perspectives. Ther. Deliv. 3, 515 (2012).
8. A. Garcia-Bennett, M. Nees, and B. Fadeel, In search of the Holy Grail: Folate-targeted nanoparticles for cancer therapy. Biochem. Pharmacol. 81, 976 (2011).
9. C. Leuner and J. Dressman, Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 50, 47 (2000).
10. B. Faller, Improving solubility in lead optimization. Am. Pharm. Rev. 7, 30 (2004).
11. J. Alsenz and M. Kansy, High throughput solubility measurement in drug discovery and development. Adv. Drug Deliv. Rev. 59, 546 (2007).
12. M. S. Ku and W. Dulin, A biopharmaceutical classification-based right-first-time formulation approach to reduce human pharmacokinetic variability and project cycle time from first-in-human to clinical proof-of-concept. Pharm. Dev. Technol. 16, 285 (2010).
13. A. M. Thayer, Custom manufacturers take on drug solubility issues to help pharmaceutical firms move products through development. Chem. Eng. News 88, 13 (2011).
14. K. T. Savjani, A. K. Gajjar, and J. K. Savjani, Drug solubility: Importance and enhancement techniques, International Scholarly Research Network, ISRN Pharmaceutics 2012, 10 (2012).
15. R. K. Jain and T. Stylianopoulos, Delivering nanomedicine to solid tumors. Nat. Rev. Clin. Oncol. 7, 653 (2010).
16. FDA approves Roche's Kadcyla (trastuzumab emtansine), the first antibody-drug conjugate for treating HER2-positive metastatic breast cancer. Available at http://www.roche.com/media/media-releases/med-cor-2013-02-22.htm (Accessed: January 2014).
17. F. Anton, Method of producing artificial fibres. U.S Patent No 2158415, May 16 (1939).
18. F. Anton, Method and apparatus for spinning. U.S Patent No 2349950, May 30 (1944).
19. F. Anton, Method and apparatus for preparing artificial threads. U.S Patent No 1975504, February 02 (1934).
20. D. Li and Y. Xia, Electrospinning of nanofibers: Reinventing the wheel? Adv. Mater. 16, 1151 (2004).
21. K. Garg and G. L. Bowlin, Electrospinning jets and nanofibrous structures. Biomicrofluidics 5, 013403 (2011).
22. D. H. Reneker, A. L. Yarin, H. Fong, and S. Koombhongse, Bending instability of electrically charged liquid jets of polymer solutions in electrospinning. J. Appl. Phys. 87, 4531 (2000).
23. D. H. Reneker and A. L. Yarin, Electrospinning jets and polymer nanofibers. Polymer 49, 2387 (2008).
24. A. L. Yarin, S. Koombhongse, and D. H. Reneker, Bending instability in electrospinning of nanofibers. J. Appl. Phys. 89, 3018 (2001).
25. Z. Ma, M. Kotaki, T. Yong, W. He, and S. Ramakrishna, Surface engineering of electrospun polyethylene terephthalate (PET) nanofibers towards development of a new material for blood vessel engineering. Biomaterials 26, 2527 (2005).
26. J. P. Chen, G. Y. Chang, and J. K. Chen, Electrospun collagen/chitosan nanofibrous membrane as wound dressing. Colloids Surf. A 313-314, 183 (2008).
27. T. G. Kim, D. S. Lee, and T. G. Park, Controlled protein release from electrospun biodegradable fiber mesh composed of poly(ε-caprolactone) and poly(ethylene oxide). Int. J. Pharm. 338, 276 (2007).
28. P. X. Ma and R. Zhang, Synthetic nano-scale fibrous extracellular matrix. J. Biomed. Mater. Res. 46, 60 (1999).
29. D. Liu, H. Zhang, P. C. M. Grim, S. de Feyter, U. M. Wiesler, A. J. Berresheim, K. Müllen, and F. C. De Schryver, Self-assembly of polyphenylene dendrimers into micrometer long nanofibers: An atomic force microscopy study. Langmuir 18, 2385 (2002).
30. G. Liu, L. Qiao, and A. Guo, Diblock copolymer nanofibers. Macromolecules 29, 5508 (1996).
31. X. Yan, G. Liu, F. Liu, B. Zhong Tang, H. Peng, A. B. Pakhomov, and C. Y. Wong, Superparamagnetic triblock copolymer/Fe2O3 hybrid nanofibers. Angew. Chem. Int. Ed. 40, 3593 (2001).
32. C. G. Wu and T. Bein, Conducting polyaniline filaments in a mesoporous channel host. Science 264, 1757 (1994).
33. L. Feng, S. Li, H. Li, J. Zhai, Y. Song, L. Jiang, and D. Zhu, Super-hydrophobic surface of aligned polyacrylonitrile nanofibers. Angew. Chem. Int. Ed. 41, 1221 (2002).
34. T. Ondarçuhu and C. Joachim, Drawing a single nanofiber over hundreds of microns. Europhys. Lett. 42, 215 (1998).
35. M. Yokoyama, Clinical applications of polymeric micelle carrier systems in chemotherapy and image diagnosis of solid tumors. J. Exp. Clin. Med. 3, 151 (2011).
36. D. Liu, C. He, A. Z. Wang, and W. Lin, Application of liposomal technologies for delivery of platinum analogs in oncology. Int. J. Nanomed. 8, 3309 (2013).
37. C. Tan, Y. Wang, and W. Fan, Exploring polymeric micelles for improved delivery of anticancer agents: Recent developments in preclinical studies. Pharmaceutics 5, 201 (2013).
38. D. G. Yu, X. F. Zhang, X. X. Shen, C. Branford-White, and L. M. Zhu, Ultrafine ibuprofen-loaded polyvinylpyrrolidone fiber mats using electrospinning. Polym. Int. 58, 1010 (2009).
39. D. G. Yu, X. X. Shen, C. Branford-White, K. White, L. M. Zhu, and S. W. A. Bligh, Oral fast-dissolving drug delivery membranes prepared from electrospun polyvinylpyrrolidone ultrafine fibers. Nanotechnology 20, 055104 (2009).
40. D. G. Yu, C. Branford-White, X. X. Shen, X. F. Zhang, and L. M. Zhu, Solid dispersions of ketoprofen in drug-loaded electrospun nanofibers. J. Dispers. Sci. Technol. 31, 902 (2010).
41. D. J. Yang, C. D. Xiong, T. Govender, and Y. Z. Wang, Preparation and drug-delivery potential of metronidazole-loaded PELA triblock copolymeric electrospun membranes. J. Biomater. Sci. Polym. 20, 1321 (2009).
42. J. Han, T. X. Chen, C. J. Branford-White, and L. M. Zhu, Electrospun shikonin-loaded PCL/ PTMC composite fiber mats with potential biomedical applications. Int. J. Pharm. 382, 215 (2009).
43. J. R. Peng, Z. Y. Qian, B. Wang B, S. Fu, G. Guo, F. Luo, R. Li, and D. Wu, Preparation and release characteristics of quercetin loaded poly(lactic acid) ultrafine fibers. J. Nanosci. Nanotechnol. 11, 3659 (2011).
44. D. G. Yu, L. D. Gao, K. White, C. Branford-White, W. Y. Lu, and L. M. Zhu, Multicomponent amorphous nanofibers electrospun from hot aqueous solutions of a poorly soluble drug. Pharm. Res. 27, 2466 (2010).
45. L. Y. Huang, D. G. Yu, L. M. Zhu, C. J. Branford-White, and K. White, Preparation of fast-dissolving ursolic acid nanofiber membranes using electrospinning, Presented at: 5th International Conference on Bioinformatics and Biomedical Engineering, Wuhan, China, May (2011).
46. Y. Park, E. Kang, O. J. Kwon, T. Hwang, H. Park, J. M. Lee, J. H. Kim, and C. O. Yun, Ionically crosslinked Ad/chitosan nanocomplexes processed by electrospinning for targeted cancer gene therapy. J. Control. Release 148, 75 (2010).
47. X. X. Shen, D. G. Yu, L. Zhu, C. Branford-White, K. White, and N. P. Chatterton, Electrospun diclofenac sodium loaded Eudragit® L 100-155 nanofibers for colon-targeted drug delivery. Int. J. Pharm. 408, 200 (2011).
48. Z. M. Huang, Y. Z. Zhang, M. Kotaki, and S. Ramakrishna, A review on polymer nanofibers by electrospinning and their applications in nanocomposites. Composites Science and Technology 63, 2223 (2003).
49. A. M. Piras, L. Nikkola, F. Chiellini, N. Ashammakhi, and E. Chiellini, Development of diclofenac sodium releasing bioerodible polymeric nanomats. J. Nanosci. Nanotechnol. 6, 3310 (2006).
50. T. Ngawhirunpat, P. Opanasopit, T. Rojanarata, P. Akkaramongkolporn, U. Ruktanonchai, and P. Supaphol, Development of meloxicam-loaded electrospun polyvinyl alcohol mats as a transdermal therapeutic agent. Pharm. Dev. Technol. 14, 70 (2006).
51. P. Taepaiboon, U. Rungsardthong, and P. Supaphol, Drug loaded electrospun mats of poly(vinyl alcohol) fibres and their release characteristics of four model drugs. Nanotechnology 17, 2317 (2006).
52. C. Xie, X. Li, X. Luo, Y. Yang, W. Cui, J. Zou, and S. Zhou, Release modulation and cytotoxicity of hydroxycamptothecin loaded electrospun fibers with 2-hydroxypropyl-β-cyclodextrin innoculations. Int. J. Pharmaceutics 391, 55 (2010).
53. A. Wei, J. Wang, X. Wang, Q. Wei, M. Ge, and D. Hou, Preparation and characterization of the electrospun nanofibers loaded with clarithromycin. J. Appl. Polym. Sci. 118, 346 (2010).
54. H. Peng, S. Zhou, T. Guo, Y. Li, X. Li, J. Wang, and J. Weng, In vitro degradation and release profiles for electrospun polymeric fibers containing paracetamol. Colloids Surf. B: Biointerfaces 66, 206 (2008).
55. M. Zamani, M. P. Prabhakaran, and S. Ramakrishna, Advances in drug delivery via electrospun and electrosprayed nanomaterials. Int. J. Nanomed. 8, 2997 (2013).
56. J. Zeng, L. Yang, Q. Liang, X. Zhang, H. Guan, X. Xu, X. Chen, and X. Jing, Influence of the drug compatibility with polymer solution on the release kinetics of electrospun fiber formulation. J. Control Release 105, 43 (2005).
57. Z. X. Meng, X. X. Xu, W. Zheng, H. M. Zhou, L. Li, Y. F. Zheng, and X. Lou, Preparation and characterization of electrospun PLGA/gelatin nanofibers as a potential drug delivery system. Colloids Surf. B Biointerfaces 84, 97 (2011).
58. X. Xu, X. Chen, Z. Wang, and X. Jing, Ultrafine PEG-PLA fibers loaded with both paclitaxel and doxorubicin hydrochloride and their in vitro cytotoxicity. Eur. J. Pharm. Biopharm. 72, 18 (2009).
59. M. Jannesari, J. Varshosaz, M. Morshed, and M. Zamani, Composite poly(vinyl alcohol)/poly(vinyl acetate) electrospun nanofibrous mats as a novel wound dressing matrix for controlled release of drugs. Int. J. Nanomedicine 6, 993 (2011).
60. H. S. Yoo, T. G. Kim, and T. G. Park, Surface-functionalized electrospun nanofibers for tissue engineering and drug delivery. Adv. Drug Deliv. Rev. 61, 1033 (2009).
61. F. Z. Volpato, J. Almodovar, K. Erickson, K. C. Popat, C. Migliaresi, and M. J. Kipper, Preservation of FGF-2 bioactivity using heparin-based nanoparticles, and their delivery from electrospun chitosan fibers. Acta Biomater. 8, 1551 (2012).
62. J. S. Im, J. Yun, Y. M. Lim, H. I. Kim, and Y. S. Lee, Fluorination of electrospun hydrogel fibers for a controlled release drug delivery system. Acta Biomater. 6, 102 (2010).
63. H. S. Kim and H. S. Yoo, MMPs-responsive release of DNA from electrospun nanofibrous matrix for local gene therapy: In vitro and in vivo evaluation. J. Control Release 145, 264 (2010).
64. F. Mottaghitalab, M. Farokhi, V. Mottaghitalab, M. Ziabari, A. Divsalar, and M. A. Shokrgozar, Enhancement of neural cell lines proliferation using nano-structured chitosan/poly(vinyl alcohol) scaffolds conjugated with nerve growth factor. Carbohydr Polym. 86, 526 (2011).
65. J. S. Choi, K. W. Leong, and H. S. Yoo, In vivo wound healing of diabetic ulcers using electrospun nanofibers immobilized with human epidermal growth factor (EGF). Biomaterials 29, 587 (2008).
66. Y. I. Cho, J. S. Choi, S. Y. Jeong, and H. S. Yoo, Nerve growth factor (NGF)-conjugated electrospun nanostructures with topographical cues for neuronal differentiation of mesenchymal stem cells. Acta Biomater. 6, 4725 (2010).
67. J. Zou, Y. Yang, Y. Liu, F. Chen, and X. Li, Release kinetics and cellular profiles for bFGF-loaded electrospun fibers: Effect of the conjugation density and molecular weight of heparin. Polymer 52, 3357 (2011).
68. E. Cho, C. Kim, J. Y. Park, C. H. Hwang, J. H. Kim, Y. A. Kim, M. Endo, D. R. Chang, and J. K. Kook, Surface modification of electrospun polyvinylene fluoride nanofiber membrane by plasma treatment for protein detection. J. Nanosci. Nanotechnol. 13, 674 (2013).
69. X. Zhu, K. S. Chian, M. B. E. Chan-Park, and S. T. Lee, Effect of argon-plasma treatment on proliferation of human-skin-derived fibroblast on chitosan membrane in vitro. J. Biomed. Mater. Res. A 73A, 264 (2005).
70. S. C. Baker, N. Atkin, P. A. Gunning, N. Granville, K. Wilson, D. Wilson, and J. Southgate, Characterization of electrospun polystyrene scaffolds for three-dimensional in vitro biological studies. Biomaterials 27, 3136 (2006).
71. H. Park, K. Y. Lee, S. J. Lee, K. E. Park, and W. H. Park, Plasma-treated poly(lactic-co-glycolic acid) nanofibers for tissue engineering. Macromol. Res. 15, 238 (2007).
72. Z. Ma, W. He, T. Yong, and S. Ramakrishna, Grafting of gelatin on electrospun poly(caprolactone) nanofibers to improve endothelial cell spreading and proliferation and to control cell orientation. Tissue Eng. 11, 1149 (2005).
73. Y. S. Nam, J. J. Yoon, J. G. Lee, and T. G. Park, Adhesion behaviours of hepatocytes cultured onto biodegradable polymer surface modified by alkali hydrolysis process. J. Biomater. Sci., Polym. Ed. 10, 1145 (1999).
74. T. I. Croll, A. J. O'Connor, G. W. Stevens, and J. J. Cooper-White, Controllable surface modification of poly(lactic-co-glycolic acid) (PLGA) by hydrolysis or aminolysis I: Physical, chemical, and theoretical aspects. Biomacromolecules 5, 463 (2004).
75. Z. M. Liu, Z. K. Xu, J. Q. Wang, J. Wu, and J. J. Fu, Surface modification of polypropylene microfiltration membranes by graft polymerization of N -vinyl-2-pyrrolidone. Eur. Polym. J. 40, 2077 (2004).
76. F. Yang, J. G. C. Wolke, and J. A. Jansen, Biomimetic calcium phosphate coating on electrospun poly(ε-caprolactone) scaffolds for bone tissue engineering. Chem. Eng. J. 137, 154 (2008).
77. H. S. Koh, T. Yong, C. K. Chan, and S. Ramakrishna, Enhancement of neurite outgrowth using nano-structured scaffolds coupled with laminin. Biomaterials 29, 3574 (2008).
78. J. Chen, B. Chu, and B. S. Hsiao, Mineralization of hydroxyapatite in electrospun nanofibrous poly(L-lactic acid) scaffolds. J. Biomed. Mater. Res. A 79A, 307 (2006).
79. Y. Zhu, M. F. Leong, W. F. Ong, M. B. Chan-Park, and K. S. Chian, Esophageal epithelium regeneration on fibronectin grafted poly(l-lactide-co- caprolactone) (PLLC) nanofiber scaffold. Biomaterials 28, 861 (2007).
80. Y. Zhu and W. F. Ong, Epithelium regeneration on collagen (IV) grafted polycaprolactone for esophageal tissue engineering. Mater. Sci. Eng.: C 29, 1046 (2009).
81. Z. Ma, M. Kotaki, T. Yong, W. He, and S. Ramakrishna, Surface engineering of electrospun polyethylene terephthalate (PET) nanofibers towards development of a new material for blood vessel engineering. Biomaterials 26, 2527 (2005).
82. K. Park, Y. M. Ju, J. S. Son, K. D. Ahn, and D. K. Han, Surface modification of biodegradable electrospun nanofiber scaffolds and their interaction with fibroblasts. J. Biomater. Sci., Polym. Ed. 18, 369 (2007).
83. A. Saraf, L. S. Baggett, R. M. Raphael, F. K. Kasper, and A. G. Mikos, Regulated non-viral gene delivery from coaxial electrospun fiber mesh scaffolds. J. Control. Release. 143, 95 (2010).
84. I. C. Liao and K. W. Leong, Efficacy of engineered FVIII-producing skeletal muscle enhanced by growth factor-releasing coaxial electrospun fibers. Biomaterials 32, 1669 (2011).
85. I. C. Liao, S. Chen, J. B. Liu, and K. W. Leong, Sustained viral gene delivery through core-shell fibers. J. Control. Release. 139, 48 (2009).
86. C. L. He, Z. M. Huang, X. J. Han, L. Liu, H. S. Zhang, and L. S. Chen, Coaxial electrospun poly(L-lactic acid) ultrafine fibers for sustained drug delivery. J. Macromol. Sci. Phys. 45, 515 (2006).
87. Z. M. Huang, C. L. He, A. Yang, Y. Zhang, X. J. Han, J. Yin, and Q. Wu, Encapsulating drugs in biodegradable ultrafine fibers through co-axial electrospinning. J. Biomed. Mater. Res A. 77, 169 (2006).
88. C. L. He, Z. M. Huang, and X. J. Han, Fabrication of drug-loaded electrospun aligned fibrous threads for suture applications. J Biomed Mater Res A. 89, 80 (2009).
89. Q. Xu, N. Zhang, W. Qin, J. Liu, Z. Jia, and H. Liu, Preparation, in vitro and in vivo evaluation of budesonide loaded core/shell nanofibers as oral colonic drug delivery system. J. Nanosci. Nanotechnol. 13, 149 (2013).
90. S. K. Tiwari, R. Tzezana, E. Zussman, and S. S. Venkatraman, Optimizing partition controlled drug release from electrospun core - shell fibers. Int. J. Pharm. 392, 209 (2010).
91. D. Han and A. J. Steckl, Triaxial electrospun nanofiber membranes for controlled dual release of functional molecules. ACS Appl. Mater. Interfaces 5, 8241 (2013).
92. M. Yoshida, R. Langer, A. Lendlein, and J. Lahann, From advanced biomedical coatings to multi-functionalized biomaterials. Polym. Rev. 46, 347 (2006).
93. J. J. Yoon, H. J. Chung, and T. G. Park, Photo-crosslinkable and biodegradable pluronic/heparin hydrogels for local and sustained delivery of angiogenic growth factor. J. Biomed. Mater. Res. A 83A, 597 (2007).
94. A. Lode, A. Reinstorf, A. Bernhardt, C. Wolf-Brandstetter, U. Konig, and M. Gelinsky, Heparin modification of calcium phosphate bone cements for VEGF functionalization. J. Biomed. Mater. Res. A 86A, 749 (2008).
95. J. S. McGonigle, G. Tae, P. S. Stayton, A. S. Hoffman, and M. Scatena, Heparin-regulated delivery of osteoprotegerin promotes vascularization of implanted hydrogels. J. Biomater. Sci., Polym. Ed. 19, 1021 (2008).
96. J. C. Stendahl, L. J. Wang, L. W. Chow, D. B. Kaufman, and S. I. Stupp, Growth factor delivery from self-assembling nanofibers to facilitate islet transplantation. Transplantation 86, 478 (2008).
97. Y. K. Joung, J. W. Bae, and K. D. Park, Controlled release of heparin-binding growth factors using heparin-containing particulate systems for tissue regeneration. Expert Opin. Drug Deliv. 5, 1173 (2008).
98. Z. Wang, B. Sun, M. Zhang, L. Ou, Y. Che, J. Zhang, and D. Kong, Functionalization of electrospun poly(ε-caprolactone) scaffold with heparin and vascular endothelial growth factors for potential application as vascular grafts. J. Bioactive Compat. Polym. 28, 154 (2013).
99. J. Lee, J. J. Yoo, A. Atala, and S. J. Lee, The effect of controlled release of PDGF-BB from heparin-conjugated electrospun PCL/gelatin scaffolds on cellular bioactivity and infiltration. Biomaterials 33, 6709 (2012).
100. X. Xu, L. Yang, X. Wang, X. Chen, Q. Liang, J. Zeng, and X. Jing, Ultrafine medicated fibers electrospun from W/O emulsions. J. Control Release 108, 33 (2005).
101. Y. Yang, X. Li, M. Qi, S. Zhou, and J. Weng, Release pattern and structural integrity of lysozyme encapsulated in core-sheath structured poly(DL-lactide) ultrafine fibers prepared by emulsion electrospinning. Eur. J. Pharm. Biopharm. 69, 106 (2008).
102. S. Yan, L. Xiaoqiang, L. Shuiping, M. Xiumei, and S. Ramakrishna, Controlled release of dual drugs from emulsion electrospun nanofibrous mats. Colloids Surf. B: Biointerfaces 73, 376 (2009).
103. E. L. Van, L. Grøndahl, K. N. Chua, K. W. Leong, V. Nurcombe, and S. M. Cool, Controlled release of heparin from PCL electrospun fibres. Biomaterials 27, 2042 (2006).
104. M. Zamani, M. Morshed, J. Varshosaz, and M. Jannesari, Controlled release of metronidazole benzoate from PCL electrospun nanofibres for periodontal diseases. Eur. J. Pharm. Biopharm. 75, 179 (2010).
105. G. Buschle-Diller, J. Cooper, Z. Xie, Y. Wu, J. Waldrup, and X. Ren, Release of antibiotics from electrospun bicomponent fibers. Cellulose 14, 553 (2007).
106. S. Y. Chew, J. Wen, E. K. F. Yim, and K. W. Leong, Sustained release of proteins from electrospun biodegradable fibers. Biomacromolecules 6, 2017 (2005).
107. X. Xu, X. Chen, X. Xu, T. Lu, X. Wang, L. Yang, and X. Jing, BCNU loaded PEG-PLLA ultrafine fibers and their in vitro anti-tumor activity against glioma C6 cells. J. Control. Release 114, 307 (2006).
108. S. H. Ranganath and C. H. Wang, Biodegradable microfiber implants delivering paclitaxel for post-surgical chemotherapy against malignant glioma. Biomaterials 29, 2996 (2008).
109. Z. Xie and G. Buschle-Diller, Electrospun poly(D,L-lactide) fibers for drug delivery: The influence of cosolvent and the mechanism of drug release. J. Appl. Polym. Sci. 115, 1 (2010).
110. W. Cui, X. Li, X. Zhu, G. Yu, S. Zhou, and J. Weng, Investigation of drug release and matrix degradation of electrospun poly(D,L-lactide) fibers with paracetamol inoculation. Biomacromolecules 7, 1623 (2006).
111. J. Zeng, L. Yang, Q. Liang, X. Zhang, H. Guan, X. Xu, X. Chen, and X. Jing, Influence of the drug compatibility with polymer solution on the release kinetics of electrospun fiber formulation. J. Control Release 105, 43 (2005).
112. R. A. Thakur, C. A. Florek, J. Kohn, and B. B. Michniak, Electrospun nanofibrous polymeric scaffold with targeted drug release profiles for potential application as wound dressing. Int. J. Pharm. 364, 87 (2008).
113. M. Qi, X. Li, Y. Yang, and S. Zhou, Electrospun fibers of acid labile biodegradable polymers containing ortho ester groups for controlled release of parcetamol. Eur. J. Pharm. Biopharm. 70, 445 (2008).
114. J. Xie and C. H. Wang, Electrospun micro- and nanofibers for sustained delivery of paclitaxel to treat C6 glioma in vitro. Pharm. Res. 23, 1817 (2006).
115. K. Kim, Y. K. Luu, C. Chang, D. Fang, B. S. Hsiao, B. Chu, and M. Hadjiargyrou, Incorporation and controlled release of a hydrophilic antibiotic using poly(lactide-co-glycolide)-based electrospun nanofibrous scaffolds. J. Control. Release 98, 47 (2004).
116. G. Verreck, I. Chun, J. Rosenblatt, J. Peeters, A. V. Dijick, J. Mensch, M. Noppe, and M. E. Brewster, Incorporation of drugs in an amorphous state into electrospun nanofibers composed of a water-insoluble, non-biodegradable polymer. J. Control Release 92, 349 (2003).
117. O. Suwatong, P. Opanasopit, U. Ruktanonchai, and P. Supaphol, Electrospun cellulose acetate fiber mats containing curcumin and release characteristics of the herbal substance. Polymer 48, 7546 (2007).
118. G. Verreck, I. Chun, J. Peeters, J. Rosenblatt, and M. E. Brewster, Preparation and characterization of nanofibers containing amorphous drug dispersions generated by electrostatic spinning. Pharm. Res. 20, 810 (2003).
119. H. Nie, B. W. Soh, Y. C. Fu, and C. H. Wang, Three-dimensional fibrous PLGA/Hap composite scaffold for BMP-2 delivery. Biotech. Bioeng. 99, 223 (2007).
120. E. R. Kenawy, G. L. Bowlin, K. Mansfield, J. Layman, D. G. Simpson, E. H. Sanders, and G. E. Wnek, Release of tetracycline hydrochloride from electrospun poly(ethylene-covinylacetate), poly(lactic acid) and a blend. J. Control Release 81, 57 (2002).
121. S. P. Lyu and D. Untereker, Degradability of polymers for implantable biomedical devices. Int. J. Mol. Sci. 10, 4033 (2009).
122. N. Goonoo, A. Bhaw-Luximon, G. L. Bowlin, and D. Jhurry, An assessment of biopolymer- and synthetic polymer-based scaffolds for bone and vascular tissue engineering. Polym. Int. 62, 523 (2013).
123. V. Uskokovi'c, Entering the era of nanoscience: Time to be so small. J. Biomed. Nanotechnol. 9, 1441 (2013).
124. M. A. Attawia, K. M. Herbert, K. E. Uhrich, R. Langer, and C. T. Laurencin, Proliferation, morphology, and protein expression by osteoblasts cultured on poly(anhydride-co-imides). J. Biomed. Mater. Res. 48, 322 (1999).
125. A. Atala and R. P. Lanza, (eds.), Methods of Tissue Engineering. Academic Press, San Diego, CA (2002).
126. S. H. Oh, S. C. Park, H. K. Kim, Y. J. Koh, J. H. Lee, M. C. Lee, and J. H. Lee, Degradation behavior of 3D porous polydioxanone-b-polycaprolactone scaffolds fabricated using the melt-molding particulate-leaching method. J. Biomater. Sci. 22, 225 (2011).
127. Y. Lochee, A. Bhaw-Luximon, D. Jhurry, and A. Kalangos, Novel biodegradable poly(ester-ether)s: Copolymers from 1,4-dioxan-2-one and d,l-3-methyl-1,4-dioxan-2-one. Macromolecules 42, 7285 (2009).
128. Y. Lochee, D. Jhurry, A. Bhaw-Luximon, and A. Kalangos, Biodegradable poly(ester-ether)s: Ring-opening polymerization of D,L-3-methyl-1,4-dioxan-2-one using various initiator systems. Polym. Int. 59, 1310 (2010).
129. N. Goonoo, A. Bhaw-Luximon, G. L. Bowlin, and D. Jhurry, Diblock poly(ester)-poly(ester-ether) copolymers: I. synthesis, thermal properties, and degradation kinetics. Ind. Eng. Chem. Res. 51, 12031 (2012).
130. S. I. Jeong, B. S. Kim, S. W. Kang, J. H. Kwon, Y. M. Lee, S. H. Kim, and Y. H. Kim, In vivo biocompatibility and degradation behavior of elastic poly(l-lactide-co-ε-caprolactone) scaffolds. Biomaterials 25, 5939 (2004).
131. N. Goonoo, A. Bhaw-Luximon, I. A. Rodriguez, G. L. Bowlin, and D. Jhurry, Biomaterials Science (2014), DOI:10.1039/c3bm60211g.
132. K. T. Shalumon, K. H. Anulekha, K. P. Chenazzhi, H. Tamura, S. V. Nair, and R. Jayakumar, Fabrication of chitosan/poly(caprolactone) nanofibrous scaffold for bone and skin tissue engineering. Int. J. Biol. Macromol. 48, 571 (2011).
133. Y. J. Lin, Q. Cai, L. Li, Q. F. Li, X. P. Yang, and R. G. Jin, Co-electrospun composite nanofibers of blends of poly[(amino acid ester) phosphazene] and gelatin. Polym. Int. 59, 610 (2010).
134. M. G. Cascone, N. Barbani, P. Giusti, C. Cristallini, G. Ciardelli, and L. Lazzeri, Bioartificial polymeric materials based on polysaccharides. J. Biomater. Sci. Polym. Ed. 12, 267 (2001).
135. V. Thomas, X. Zhang, and Y. K. Vohra, A biomimetic tubular scaffold with spatially designed nanofibers of protein/PDS® bio-blends. Biotechnol. Bioeng. 104, 1025 (2009).
136. V. Pillay, C. Dott, Y. E. Choonara, C. Tyagi, L. Tomar, P. Kumar, L. C. du Toit, and V. M. K. Ndesendo, A review of the effect of processing variables on the fabrication of electrospun nanofibers for drug delivery applications. J. Nanomater. http://dx.doi.org/10.1155/2013/789289 (2013).
137. G. Buschle-Diller, J. Cooper, Z. Xie, Y. Wu, J. Waldrup, and X. Ren, Release of antibiotics from electrospun bicomponent fibers. Cellulose 14, 553 (2007).
138. H. Cao, X. Jiang, C. Chai, and S. Y. Chew, RNA interference by nanofiber-based siRNA delivery system. J. Control. Release. 144, 203 (2010).
139. K. Kim, Y. K. Luu, C. Chang, D. Fang, B. S. Hsiao, B. Chu, and M. Hadjiargyrou, Incorporation and controlled release of a hydrophilic antibiotic using poly(lactide-co-glycolide)-based electrospun nanofibrous scaffolds. J. Control. Release 98, 47 (2004).
140. A. Kraitzer, L. Ofek, R. Schreiber, and M. Zilberman, Long-term in vitro study of paclitaxel-eluting bioresorbable core/shell fiber structures. J. Control. Release 126, 139 (2008).
141. Z. X. Meng, W. Zheng, L. Li, and Y. F. Zheng, Fabrication, characterization and in vitro drug release behavior of electrospun PLGA/chitosan nanofibrous scaffold. Mater. Chem. Phys. 125, 606 (2011).
142. R. Kenawy, G. L. Bowlin, K. Mansfield, J. Layman, D. G. Simpson, E. H. Sanders, and G. E. Wnek, Release of tetracycline hydrochloride from electrospun poly(ethylene-co-vinylacetate), poly(lactic acid), and a blend. J. Control. Release 81, 57 (2002).
143. E. Luong-Van, L. Grondahl, K. N. Chua, K. W. Leong, V. Nurcombe, and S. M. Cool, Controlled release of heparin from PCL electrospun fibers. Biomaterials 27, 2042 (2006).
144. Q. Wang, X. Hu, Y. Du, and J. F. Kennedy, Alginate/starch blend fibers and their properties for drug controlled release. Carbohydr. Polym. 82, 842 (2010).
145. M. V. Natu, H. C. De Souza, and M. H. Gil, Active Implants and Scaffolds for Tissue Regeneration, edited by M. Zilberman, Studies in Mechanobiology, Springer (2011), Chap. 8, p. 57.
146. A. Baji, Y. W. Mai, S. C. Wong, M. Abtahi, and P. Chen, Electrospinning of polymer nanofibers: Effects on oriented morphology, structures and tensile properties. Compos. Sci. Technol. 70, 703 (2010).
147. S. C. Wong, A. Baji, and S. W. Leng, Effect of fiber diameter on tensile properties of electrospun poly(ε-caprolactone). Polymer 21, 4713 (2008).
148. A. Arinstein, M. Burman, O. Gendelman, and E. Zussman, Effect of supramolecular structure on polymer nanofibre elasticity. Nat. Nanotech 2, 59 (2007).
149. E. P. S. Tan, S. Y. Ng, and C. T. Lim, Tensile testing of a single ultrafine polymeric fiber. Biomaterials 26, 1453 (2005).
150. E. Zussman, M. Burman, A. L. Yarin, R. Khalfin, and Y. Cohen, Tensile deformation of electrospun nylon-6,6 nanofibers. J. Polym. Sci. Part B: Polym. Phys. 44, 1482 (2006).
151. V. Milleret, B. Simona, P. Neuenschwander, and H. Hall, Tuning electrospinning parameters for production of 3D-fiber-fleeces with increased porosity for soft tissue engineering applications. Eur. Cells Mater. 21, 286 (2011).
152. C. Vaquette and J. J. Cooper-White, Increasing electrospun scaffold pore size with tailored collectors for improved cell penetration. Acta Biomater. 7, 2544 (2011).
153. W. H. Kim, K. H. Lee, M. S. Khil, S. Y. Ho, and H. Y. Kim, The effect of molecular weight and the linear velocity of drum surface on the properties of electrospun poly(ethylene terephthalate) nonwovens. Fiber Polym. 5, 122-127 (2004).
154. V. Thomas, M. V. Jose, S. Chowdhury, J. F. Sullivan, D. R. Dean, and Y. K. Vohra, Mechano-morphological studies of aligned nanofibrous scaffolds of polycaprolactone fabricated by electrospinning. J. Biomater. Sci. Polym. Ed. 17, 969 (2006).
155. M. Zhang, K. R. Atkinson, and R. H. Baughman, Multifunctional carbon nanotube yarns by downsizing an ancient technology. Science 306, 1358 (2004).
156. S. J. Lee, S. H. Oh, J. Liu, S. Soker, A. Atala, and J. J. Yoo, The use of thermal treatments to enhance the mechanical properties of electrospun poly(ε-caprolactone) scaffolds. Biomaterials 29, 1422 (2008).
157. J. Rnjak-Kovacina, S. G. Wise, Z. Li, P. K. M. Maitz, C. J. Young, Y. Wang, and A. S. Weiss, Tailoring the porosity and pore size of electrospun synthetic human elastin scaffolds for dermal tissue engineering. Biomaterials 32, 6729 (2011).
158. N. M. Neves, R. Campos, A. Pedro, J. Cunha, F. Macedo, and R. L. Reis, Patterning of polymer nanofiber meshes by electrospinning for biomedical applications. Int. J. Nanomed. 2, 433 (2007).
159. P. A. Madurantakam, I. A. Rodriguez, K. Garg, J. Mc Cool, P. C. Moon, and G. L. Bowlin, Compression of multilayered composite electrospun scaffolds: A novel strategy to rapidly enhance mechanical properties and three dimensionality of bone scaffolds. Adv. Mater. Sci. Eng. 2013, 9 (2013).
160. L. G. Donaruma, Definitions in biomaterials, edited by D. F. Williams, J. Polym. Sci.: Polym. Lett. Ed. Elsevier, Amsterdam (1987), Vol. 26, pp. 414-422.
161. D. S. Kohane and R. Langer, Biocompatibility and drug delivery systems. Chem. Sci. 1, 441 (2010).
162. J. M. Anderson, In vivo biocompatibility of implantable delivery systems and biomaterials. Eur. J. Pharm. Biopharm. 40, 1 (1994).
163. D. S. Kohane, M. Lipp, R. C. Kinney, D. C. Anthony, D. N. Louis, N. Lotan, and R. Langer, Biocompatibility of lipid-protein-sugar particles containing bupivacaine in the epineurium. J. Biomed. Mater. Res. Part A 59, 450 (2002).
164. D. S. Kohane, J. Y. Tse, Y. Yeo, R. Padera, M. Shubina, and R. Langer, Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum. J. Biomed. Mater. Res. A 77a, 351 (2006).
165. T. F. Slater, B. Sawyer, and U. Straeuli, Studies on succinatetetrazolium reductase systems. III. Points of coupling of four different tetrazolium salts. Biochim. Biophys. Acta 77, 383 (1963).
166. H. Epstein-Barash, I. Shichor, A. H. Kwon, S. Hall, M. W. Lawlor, R. Langer, and D. S. Kohane, Prolonged duration local anesthesia with minimal toxicity. Proc. Natl. Acad. Sci. U.S.A. 106, 7125 (2009).
167. S. P. Hudson, R. F. Padera, R. Langer, and D. S. Kohane, Biocompatibility of mesoporous silicates. Biomaterials 29, 4045 (2008).
168. D. S. Kohane, N. Plesnila, S. S. Thomas, D. Le, R. Langer, and M. A. Moskowitz, Lipid-sugar particles for intracranial drug delivery: Safety and biocompatibility. Brain Res. 946, 206 (2002).
169. D. S. Kohane, S. E. Smith, D. N. Louis, G. Colombo, P. Ghoroghchian, N. G. Hunfeld, C. B. Berde, and R. Langer, Prolonged duration local anesthesia from tetrodotoxin-enhanced local anesthetic microspheres. Pain 104, 415 (2003).
170. R. Padera, E. Bellas, J. Y. Tse, D. D. Hao, and D. S. Kohane, Local myotoxicity from sustained release of bupivacaine from microparticles. Anesthesiology 108, 921 (2008).
171. E. Fournier, C. Passirani, C. N. Montero-Menei, and J. P. Benoit, Biocompatibility of implantable synthetic polymeric drug carriers: Focus on brain biocompatibility. Biomaterials 24, 3311 (2003).
172. L. Tang and J. W. Eaton, Inflammatory responses to biomaterials. Am. J. Clin. Pathol. 103, 466 (1995).
173. Y. Yeo, M. Adil, E. Bellas, A. Astashkhina, N. Chaudary, and D. S. Kohane, Prevention of peritoneal adhesions with an in situ cross-linkable hyaluronan hydrogel delivering budesonide. J. Control. Release 120, 178 (2007).
174. T. Ito, I. P. Fraser, Y. Yeo, C. B. Highley, E. Bellas, and D. S. Kohane, Anti-inflammatory function of an in situ crosslinkable conjugate hydrogel of hyaluronic acid and dexamethasone. Biomaterials 28, 1778 (2007).
175. M. Goldberg, R. Langer, and X. Jia, Nanostructured materials for applications in drug delivery and tissue engineering. J. Biomater. Sci., Polym. Ed. 18, 241 (2007).
176. G. Pradilla, P. P. Wang, P. Gabikian, K. Li, C. A. Magee, K. A. Walter, and H. Brem, Local intracerebral administration of paclitaxel with the paclimer delivery system: Toxicity study in a canine model. J. Neurooncol. 76, 131 (2006).
177. J. Xie, R. S. Tan, and C. H. Wang, Biodegradable microparticles and fibre fabrics for sustained delivery of cisplatin to treat C6 glioma in vitro. J. Biomed. Mater. Res. A 85, 897 (2008).
178. T. Amna, N. A. M. Barakat, M. Shamshi-Hassan, M. S. Khil, and H. Y. Kim, Camptothecin loaded poly(ε-caprolactone) nanofibers via one-step electrospinning and their cytotoxicity impact. Colloids Surf. A: Physicochem. Eng. Aspects 431, 1 (2013).
179. R. P. Hertzberg, M. J. Caranfa, and S. M. Hecht, On the mechanism of topoisomerase I inhibition by camptothecin: Evidence for binding to an enzyme-DNA complex. Biochemistry 28, 4629 (1989).
180. D. Liu, S. Liu, X. Jing, X. Li, W. Li, and Y. Huang, Necrosis of cervical carcinoma by dichloroacetate released from electrospun polylactide mats. Biomaterials 33, 4362 (2012).
181. X. Luo, C. Xie, H. Wang, C. Liu, S. Yan, and X. Li, Antitumor activities of emulsion electrospun fibers with core loading of hydroxycamptothecin via intratumoral implantation. Int. J. Pharm. 425, 19 (2012).
182. F. M. Chen, M. Zhang, and Z. F. Wu, Toward delivery of multiple growth factors in tissue engineering. Biomaterials 31, 6279 (2010).
183. I. I. Tabata, The importance of drug delivery systems in tissue engineering. Pharm. Sci. Technol. Today 3, 80 (2000).
184. A. Schneider, X. Y. Wang, D. L. Kaplan, J. A. Garlick, and C. Egles, Biofunctionalized electrospun silk mats as a topical bioactive dressing for accelerated wound healing. Acta Biomater. 5, 2570 (2009).
185. F. Z. Volpato, J. Almodovar, K. Erickson, K. C. Popat, C. Migliaresi, and M. J. Kipper, Preservation of FGF-2 bioactivity using heparin-based nanoparticles, and their delivery from electrospun chitosan fibers. Acta Biomater. 8, 1551 (2012).
186. R. B. Montero, X. Vial, and F. M. Andreopoulous, bFGF-containing electrospun gelatin scaffolds with controlled nano-architectural features for directed angiogenesis. Acta Biomater. 8, 1778 (2012).
187. H. Zhang, X. Jia, F. Han, J. Zhao, Y. Fan, and X. Yuan, Dualdelivery of VEGF and PDGF by double-layered electrospun membranes for blood vessel regeneration. Biomaterials 34, 2202 (2013).
188. N. Han, J. Johnson, J. J. Lannutti, and J. O. Winter, Hydrogelelectrospun fiber composite materials for hydrophilic protein release. J. Control. Release 158, 165 (2012).
189. M. Yamamoto and Y. Tabata, Tissue engineering by modulated gene delivery. Adv Drug Deliv. Rev. 58, 535 (2006).
190. Y. K. Luu, K. Kim, B. S. Hsiao, B. Chu, and M. Hadjiargyrou, Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA-PEG block copolymers. J. Control Release 89, 341 (2003).
191. A. J. Meinel, O. Gemershaus, T. Luhmann, H. P. Merkle, and L. Meinel, Electrospun matrices for localized drug delivery: Current technologies and selected biomedical applications. Eur. J. Pharm. Biopharm. 81, 1 (2012).
192. H. Cao, X. Jiang, C. Chai, and S. Y. Chew, RNA interference by nanofiber-based siRNA delivery system. J. Control. Release 144, 203 (2010).
193. P. O. Rujitanaroj, Y. C. Wang, J. Wang, and S. Y. Chew, Nanofiber-mediated controlled release of siRNA complexes for long term gene-silencing applications. Biomaterials 32, 5915 (2011).
194. M. Chen, S. Gao, M. Dong, J. Song, C. Yang, K. A. Howard, J. Kjems, and F. Besebacher, Chitosan/siRNA nanoparticles encapsulated in PLGA nanofibers for siRNA delivery. ACS Nano 6, 4835 (2012).
195. Y. Zhang, C. T. Lim, S. Ramakrishna, and Z. M. Huang, Recent development of polymer nanofibers for biomedical and biotechnological applications. J. Mater. Sci. Mater. Med. 16, 933 (2005).
196. L. Tian, M. P. Prabhakaran, X. Ding, D. Kai, and S. Ramakrishna, Emulsion electrospun vascular endothelial growth factor encapsulated poly(l-lactic acid-co-ε-caprolactone) nanofibers for sustained release in cardiac tissue engineering. J. Mater. Sci. 47, 3272 (2011).
197. J. Chen, B. Zhou, and M. M. Q. Xing, PLLA-PEG-TCHlabeled bioactive molecule nanofibers for tissue engineering. Int. J. Nanomed. 6, 2533 (2011).
198. A. Yamawaki-Ogata, R. Hashizume, M. Satake, H. Kaneko, S. Mizutani, and T. Moritan, A doxycycline loaded, controlled release, biodegradable fiber for the treatment of aortic aneurysms. Biomaterials 31, 9554 (2010).
199. N. Bolgen, I. Vargel, P. Korkusuz, Y. Z. Menceloglu, and E. Piskin, In vivo performance of antibiotic embedded electrospun PCL membranes for prevention of abdominal adhesions. J. Biomed. Mater. Res. Part B: Appl. Biomaterials. 81, 530 (2007).
200. Y. Hong, K. Fujimoto, R. Hashizume, J. Guan, J. J. Stankus, K. Tobita, and W. R. Wagner, Generating elastic, biodegradable polyurethane/poly(lactide- co-glycolide) fibrous sheets with controlled antibiotic release via two-Stream electrospinning. Biomacromolecules 9, 1200 (2008).
201. C. Hu, S. Liu, Y. Zhang, B. Li, H. Yang, C. Fan, and W. Cui, Long-term drug release from electrospun fibers for in vivo inflammation prevention in the prevention of peritendinous adhesions. Acta Biomater. 9, 7381 (2013).
202. E. Valazero, M. Stanzione, L. Tammaro, L. Cartuche, O. Malagon, and V. Vittoria, Preparation, characterization and anti-bacterial activity of poly(ε-caprolactone) electrospun fibers loaded with amoxicillin for controlled release in biomedical applications. J. Nanosci. Nanotechnol. 13, 1717 (2013).
203. Y. Shi, Z. Wei, H. Zhao, T. Liu, A. Dong, and J. Zhang, Electrospinning of ibuprofen loaded composite nanofibers for improving the performances of transdermal patches. J. Nanosci. Nanotechnol. 13, 3855 (2013).
204. T. H. B. Eriksen, E. Skovsen, and P. Fojan, Release of antimicrobial peptides from electrospun nanofibers as a drug delivery system. J. Biomed. Nanotechnol. 9, 492 (2013).
205. L. Jiang, H. Sun, A. Yuan, K. Zhang, D. Li, C. Li, C. Shi, X. Li, K. Gao, and C. Zheng, Enhancement of osteoinduction by continual simvastatin release from poly(lactic-co-glycolic acid)-hydroxyapatite-simvastatin nanofibrous scaffold. J. Biomed. Nanotechnol. 9, 1921 (2013).
206. E. N. James and L. S. Nair, Development and characterization of lactoferrin loaded poly(ε-caprolactone) nanofibers. J. Biomed. Nanotechnol. 10, 500 (2014).
207. N. Bolgen, I. Vargel, P. Korkusuz, Y. Z. Menceloglu, and E. Piskin, In vivo performance of antibiotic embedded electrospun PCL membranes for prevention of abdominal adhesions. J. Biomed. Mater. Res. B: Appl. Biomaterials 81, 530 (2007).
208. X. Zong, S. Li, B. Garlick, K. S. Kim, D. Fang, J. Chiu, T. Zimmerman, C. Braithwate, B. S. Hsiao, and B. Chu, Prevention of postsurgery-induced abdominal adhesions by electrospun bioabsorbable nanofibrous poly(lactide-co-glycolide)-based membranes. Ann. Surg. 240, 910 (2004).
209. X. Luo, G. Xu, H. Song, S. Yang, S. Yan, G. Jia, and X. Li, Promoted antitumor activities of acid-labile electrospun fibers loaded with hydroxycamptothecin via intratumoral implantation. Eur. J. Pharm. Biopharm. 82, 545 (2012).
210. Q. Zhan, B. Shen, X. Deng, H. Chen, J. Jin, X. Zhang, C. Peng, and H. Li, Drug-eluting scaffold to deliver chemotherapeutic medication for management of pancreatic cancer after surgery. Int. J. Nanomed. 8, 2465 (2013).
211. R. Toshkova, N. Manolova, E. Gardeva, M. Ignatova, L. Yossifova, I. Rashkov, and M. Alexandrov, Antitumor activity of quaternized chitosan-based electrospun implants against Graffi myeloid tumor. Int. J. Pharm. 400, 221 (2010).
212. Y. Zhu, C. Hu, B. Li, H. Yang, Y. Cheng, and W. Cui, A highly flexible paclitaxel-loaded poly(e-caprolactone) electrospun fibrous-membrane-covered stent for benign cardia stricture. Acta Biomater. 9, 8328 (2013).
213. H. S. Kim and H. S. Yoo, In vitro and in vivo epidermal growth factor gene therapy for diabetic ulcers with electrospun fibrous meshes. Acta Biomater. 9, 7371 (2013).
214. N. Charernsriwilaiwat, P. Opanasopit, T. Rojanarata, and T. Ngawhirunpat, Lysozyme-loaded, electrospun chitosan-based nanofiber mats for wound healing. Int. J. Pharm. 427, 379 (2012).
215. T. Nitanan, P. Akkaramongkolporn, T. Rojanarata, T. Ngawhirunpat, and P. Opanasopit, Neomycin-loaded poly(styrene sulfonic acid-co-maleic acid) (PSSA-MA)/polyvinyl alcohol (PVA) ion exchange nanofibers for wound dressing materials. Int. J. Pharm. 448, 71 (2013).
216. S. S. Said, O. M. El-Halfawy, H. M. El-Gowelli, A. K. Aloufy, N. A. Boraei, and L. K. El-Khordaqui, Bioburden-responsive antimicrobial PLGA ultrafine fibers for wound healing. Eur. J. Pharm. Biopharm. 80, 85 (2012).
217. G. T. Garg, B. Malik, G. Rath, and A. K. Goyal, Development and characterization of nano-fiber patch for the treatment of glaucoma. Eur. J. Pharm. Sci. 53, 10 (2014).
218. S. E. Gilchrist, D. Lange, K. Letchford, H. Bach, L. Fazli, and H. M. Burt, Fusidic acid and rifampicin co-loaded PLGA nanofibers for the prevention of orthopedic implant associated infections. J. Control Release 170, 64 (2013).
219. J. Kim, W. J. Kim, S. J. Kim, C. W. Cho, and S. C. Shin, Release characteristics of quinupramine from the ethylene-vinyl acetate matrix. Int. J. Pharm. 315, 134 (2006).
220. Y. Xie, B. Xu, and Y. Gao, Controlled transdermal delivery of model drug compounds by MEMS microneedle array. Nanomedicine 1, 184 (2005).
221. D. C. Monkhouse and A. S. Huq, Transdermal drug delivery-problems and promises. Drug Dev. Ind. Pharm. 14, 183 (1988).
222. P. Taepaiboon, U. Rungsardthong, and P. Supaphol, Vitamin-loaded electrospun cellulose acetate nanofiber mats as transdermal and dermal therapeutic agents of vitamin A acid and vitamin E. Eur. J. Pharm. Biopharm. 67, 387 (2007).
223. C. Y. Park, Y. G. Lee, C. Oh, and S. G. Oh, Preparation of poly-(NIPAM) grafted hybrid silica particles with hollow structure in emulsion. J. Ind. Eng. Chem. 16, 32 (2010).
224. L. F. Gudeman and N. A. Peppas, PH-Sensitive membrane from poly(vinyl alcohol)/poly(acrylic acid) interpenetrating networks. J. Membr. Sci. 107, 239 (1995).
225. X. Yang and J. C. Kim, PH-Dependent release of blue dextran from carboxymethyl-b-cyclodextrin hydrogels. J. Ind. Eng. Chem. 16, 763 (2010).
226. J. Yun, J. S. Im, Y. S. Lee, and H. I. Kim, Electro-responsive transdermal drug delivery behavior of PVA/PAA/MWCNT nanofibers. Eur. Polym. J. 47, 1893 (2011).
227. S. D. Bonnet, S. L. Archer, J. Allalunis-Turner, A. Haromy, C. Beaulieu, R. Thompson, C. T. Lee, G. D. Lopaschuk, L. Puttagunta, S. Bonnet, G. Harry, K. Hashimoto, C. J. Porter, M. A. Andrade, B. Thebaud, and E. D. Michekalis, A mitochondria-Kp channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 11, 37 (2007).
228. D. Brandsma, T. P. C. Dorlo, J. H. Haanen, J. H. Beijnen, and W. Boogerd, Severe encephalopathy and polyneuropathy induced by dichloroacetate.J. Neurol. 257, 2099 (2010).
229. P. W. Stacpoole, N. V. Nagaraja, and A. D. Hutson, Efficacy of dichloroacetate as a lactate-lowering drug. J. Clin. Pharmacol. 43, 683 (2003).
230. A. C. Liang and L. I. H. Chen, Fast-dissolving intraoral drug delivery systems. Expert Opin. Ther. Pat. 11, 981 (2001).
231. H. Seager, Drug-delivery products and the Zydis fast-dissolving dosage form. J. Pharm. Pharmacol. 50, 375 (1998).
232. Y. Fu, S. Yang, S. H. Jeong, S. Kimura, and K. Park, Orally fast disintegrating tablets: Developments, technologies, taste-masking and clinical studies. Crit. Rev. Ther. Drug Carrier Syst. 21, 433 (2004).
233. S. Schiermeier and P. C. Schmidt, Fast dispersible ibuprofen tablets. Eur. J. Pharm. Sci. 15, 295 (2002).
234. T. Purvis, M. E. Mattucci, M. T. Crisp, K. P. Johnston, and R. O. Williams, Rapidly dissolving repaglinide powders produced by the ultra-rapid freezing process. AAPS Pharm-Sci Tech 8, 52 (2007).
235. X. Li, M. A. Kanjwal, L. Lin, and I. S. Chronakis, Electrospun polyvinyl-alcohol nanofibers as oral fast-dissolving delivery system of caffeine and riboflavin. Colloids Surf. B: Biointerfaces 103, 182 (2013).
236. P. Vrbata, P. Berka, D. Stranska, P. Dolezal, M. Musilova, and L. Cizinski, Electrospun drug loaded membranes for sublingual administration of sumatriptan and naproxen. Int. J. Pharm. 457, 168 (2013).
237. Y. Wang, B. Wang, W. Qiao, and T. Yin, A novel controlled release drug delivery system for multiple drugs based on electrospun nanofibers containing nanoparticles. J. Pharm. Sci. 99, 4805 (2010).
238. J. Hu, F. Zeng, J. Wei, Y. Chen, and Y. Chen, Novel controlled drug delivery system for multiple drugs based on electrospun nanofibers containing nanomicelles. J. Biomater. Sci. Polym. Ed. (2013), In Press.